Prospectives for the use of nanomaterials in nanodiagnostic

Detalhes bibliográficos
Autor(a) principal: Santos, João.M.
Data de Publicação: 2014
Outros Autores: Rodrigues, S.M., Ribeiro, D.M., Prior, J.V.
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45
Resumo: Conventional diagnostic methods are exclusively focused on the detection of the symptoms associated to a given pathology. Any process able to determine with anticipation the occurrence of a disease, inclusively before the first symptoms, or providing the means to predict the possibility of occurrence of that disease, would significantly reinforce the effectiveness of the therapy allowing, at the same time, the establishment of prevention measures to avoid its progression. Much of the worldwide health research aims at the development of expedite devices or strategies capable of carrying out the monitoring of first level signs, or able to early detect and quantify biomarkers, usually at very low concentrations, associated to a given illness. In the search for alternative diagnostic methods able to overcome the limitations of available technology nanomaterials assume a decisive role and anticipate extremely promising developments in healthcare medicine. 
id RCAP_5fe54ca999b92a4c66f944567954455e
oai_identifier_str oai:ojs.actafarmaceuticaportuguesa.com:article/45
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Prospectives for the use of nanomaterials in nanodiagnosticPerspetivas de utilização de nanomateriais em nanodiagnósticoNanomedicinenanodiagnosticsnanomaterialsquantum dotsmetallic nanoparticlesNanomedicinananodiagnósticonanomateriaispontos quânticosnanopartículas metálicasConventional diagnostic methods are exclusively focused on the detection of the symptoms associated to a given pathology. Any process able to determine with anticipation the occurrence of a disease, inclusively before the first symptoms, or providing the means to predict the possibility of occurrence of that disease, would significantly reinforce the effectiveness of the therapy allowing, at the same time, the establishment of prevention measures to avoid its progression. Much of the worldwide health research aims at the development of expedite devices or strategies capable of carrying out the monitoring of first level signs, or able to early detect and quantify biomarkers, usually at very low concentrations, associated to a given illness. In the search for alternative diagnostic methods able to overcome the limitations of available technology nanomaterials assume a decisive role and anticipate extremely promising developments in healthcare medicine. Os métodos de diagnósticos convencionais estão exclusivamente empenhados na deteção de sintomas associados a uma dada patologia. Qualquer processo que permita determinar o mais antecipadamente possível a ocorrência da doença, inclusive antes de surgirem os primeiros indícios, ou que permita avaliar o risco da doença ocorrer, reforçaria significativamente as hipóteses de sucesso da terapia e tornaria até praticável tomar medidas preventivas para evitar a sua progressão. Muita da investigação em curso na área da medicina passa pelo desenvolvimento de estratégias ou dispositivos capazes de efetuar a monitorização, o mais antecipadamente possível, destes indícios, ou então capazes de detetar e quantificar precocemente marcadores biológicos, usualmente em concentrações muito baixas, associados a uma dada patologia. Na pesquisa por métodos de diagnósticos alternativos, aptos a ultrapassar algumas das limitações dos métodos atuais, os nanomateriais assumem um papel decisivo e abrem perspetivas de desenvolvimento extremamente promissoras para a área do nanodiagnóstico. Acta Farmacêutica Portuguesa2014-07-01T00:00:00Zjournal articleinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45oai:ojs.actafarmaceuticaportuguesa.com:article/45Acta Farmacêutica Portuguesa; v. 3 n. 1 (2014); 3-142182-3340reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45/54https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45/76Santos, João.M.Rodrigues, S.M.Ribeiro, D.M.Prior, J.V.info:eu-repo/semantics/openAccess2022-09-05T12:29:45Zoai:ojs.actafarmaceuticaportuguesa.com:article/45Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T14:59:54.110256Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Prospectives for the use of nanomaterials in nanodiagnostic
Perspetivas de utilização de nanomateriais em nanodiagnóstico
title Prospectives for the use of nanomaterials in nanodiagnostic
spellingShingle Prospectives for the use of nanomaterials in nanodiagnostic
Santos, João.M.
Nanomedicine
nanodiagnostics
nanomaterials
quantum dots
metallic nanoparticles
Nanomedicina
nanodiagnóstico
nanomateriais
pontos quânticos
nanopartículas metálicas
title_short Prospectives for the use of nanomaterials in nanodiagnostic
title_full Prospectives for the use of nanomaterials in nanodiagnostic
title_fullStr Prospectives for the use of nanomaterials in nanodiagnostic
title_full_unstemmed Prospectives for the use of nanomaterials in nanodiagnostic
title_sort Prospectives for the use of nanomaterials in nanodiagnostic
author Santos, João.M.
author_facet Santos, João.M.
Rodrigues, S.M.
Ribeiro, D.M.
Prior, J.V.
author_role author
author2 Rodrigues, S.M.
Ribeiro, D.M.
Prior, J.V.
author2_role author
author
author
dc.contributor.author.fl_str_mv Santos, João.M.
Rodrigues, S.M.
Ribeiro, D.M.
Prior, J.V.
dc.subject.por.fl_str_mv Nanomedicine
nanodiagnostics
nanomaterials
quantum dots
metallic nanoparticles
Nanomedicina
nanodiagnóstico
nanomateriais
pontos quânticos
nanopartículas metálicas
topic Nanomedicine
nanodiagnostics
nanomaterials
quantum dots
metallic nanoparticles
Nanomedicina
nanodiagnóstico
nanomateriais
pontos quânticos
nanopartículas metálicas
description Conventional diagnostic methods are exclusively focused on the detection of the symptoms associated to a given pathology. Any process able to determine with anticipation the occurrence of a disease, inclusively before the first symptoms, or providing the means to predict the possibility of occurrence of that disease, would significantly reinforce the effectiveness of the therapy allowing, at the same time, the establishment of prevention measures to avoid its progression. Much of the worldwide health research aims at the development of expedite devices or strategies capable of carrying out the monitoring of first level signs, or able to early detect and quantify biomarkers, usually at very low concentrations, associated to a given illness. In the search for alternative diagnostic methods able to overcome the limitations of available technology nanomaterials assume a decisive role and anticipate extremely promising developments in healthcare medicine. 
publishDate 2014
dc.date.none.fl_str_mv 2014-07-01T00:00:00Z
dc.type.driver.fl_str_mv journal article
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45
oai:ojs.actafarmaceuticaportuguesa.com:article/45
url https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45
identifier_str_mv oai:ojs.actafarmaceuticaportuguesa.com:article/45
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45
https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45/54
https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/45/76
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Acta Farmacêutica Portuguesa
publisher.none.fl_str_mv Acta Farmacêutica Portuguesa
dc.source.none.fl_str_mv Acta Farmacêutica Portuguesa; v. 3 n. 1 (2014); 3-14
2182-3340
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799129871027273728